Cap Raise Crucible: Canaccord leads big mining dash for cash
Roundup of 35 ASX capital raisings seeking a combined $687.5m in late August and early September, led by mining deals; Canaccord Genuity topped the broker table and three IPOs floated.
Investor · 1 deal
Every published round Alpine Capital took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Mount Ridley Mines | Unnamed stage | 11 Sep 2026 | $2m | Lead | The Age Business, SMH Business |
Companies Alpine Capital has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Mount Ridley Mines | 11 Sep 2026 | 1 | 1 |
Fund closes reported for Alpine Capital, as distinct from the investments it has made.
Companies Alpine Capital has backed that another company then bought. An exit for the holding, not a deal Alpine Capital did.
Stories naming Alpine Capital. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of 35 ASX capital raisings seeking a combined $687.5m in late August and early September, led by mining deals; Canaccord Genuity topped the broker table and three IPOs floated.
Roundup tallies 35 ASX equity fundraises seeking $687.5 million, mostly miners; Canaccord Genuity led broker mandates with nine deals, while FireFly Metals' $190 million package was the period's largest.
Also The Age Business
Activeport, an Australian network automation firm, has locked in a A$3.634m equity placement. Fund manager Antipodes Partners and Scobie Ward joined as backers; MWP Partners followed on. Antipodes now holds about 5.1% voting power.
Australian vehicle-subscription firm Carbar and UAE counterpart Carasti have combined under a Singapore-headquartered parent, ownership split 55/45 between their shareholders; a capital raising is under way to bankroll the combined group's expansion.
Australian nanobiotech firm Nexsen has begun trading on the sharemarket after an $8m IPO; earlier government grants and an RMIT research collaboration are also noted.